Filing Flows › Aclaris Therapeutics (ACRS) › Who owns the stock
Who owns Aclaris Therapeutics (ACRS) stock
143 funds reported Aclaris Therapeutics (ACRS) shares in their latest 13F filings, worth $647M in all. The largest holder is RA Capital Management, L.P. ($67.3M). Last quarter 86 funds added to their stakes and 44 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| RA Capital Management, L.P. | 12,723,026 | $67.3M | increase | 2026-06-30 |
| BML Capital Management, LLC | 11,975,000 | $63.3M | decrease | 2026-06-30 |
| BlackRock | 10,037,008 | $53.1M | increase | 2026-06-30 |
| Deep Track Capital, LP | 9,345,000 | $49.4M | unchanged | 2026-06-30 |
| Vivo Capital, LLC | 6,694,637 | $35.4M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 5,817,866 | $30.8M | increase | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 4,925,374 | $26.1M | unchanged | 2026-06-30 |
| Rock Springs Capital Management LP | 4,330,532 | $22.9M | decrease | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 4,071,000 | $21.5M | increase | 2026-06-30 |
| Decheng Capital LLC | 4,041,736 | $21.4M | unchanged | 2026-06-30 |
| Vanguard Group | 6,502,080 | $19.6M | decrease | 2025-12-31 |
| Kalehua Capital Management LLC | 3,664,730 | $19.4M | increase | 2026-06-30 |
| State Street | 3,255,340 | $17.2M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 3,190,058 | $16.9M | increase | 2026-06-30 |
| Balyasny Asset Management L.P. | 2,023,470 | $10.7M | decrease | 2026-06-30 |
Aclaris Therapeutics' latest quarter
Aclaris Therapeutics, Q3 2026: revenue $1.5M (-55% year over year), net loss $18.5M, operating cash flow −$24.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ACRS stock?
By the latest 13F filings: RA Capital Management, L.P. ($67.3M); BML Capital Management, LLC ($63.3M); BlackRock ($53.1M); Deep Track Capital, LP ($49.4M); Vivo Capital, LLC ($35.4M).
What is the short interest in ACRS?
15,027,284 shares were sold short at the 2026-10-15 settlement, -17.39% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.